UNSPSC 51284031: Doxycycline phosphate

This classification denotes a tetracycline antibiotic with the molecular formula C22H24N2O8.H3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QG2V1M96HM. European Medicines Agency schedules doxycycline phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01833MIG. Most nations, for tariff and trade purposes, schedule doxycycline phosphate under HS 29413000 and SITC 54133. As of Q4 2014, DOXYCYCLINE PHOSPHATE remains US FDA's Preferred Term for this commodity.

Doxycycline phosphate bears US NLM identifiers UMLS ID CL436807 and NCI Concept Code C102526. SMILES: C[C@H]1C2CCCC(C2C(=O)C3=C([C@]4([C@@H]([C@H]([C@H]13)O)[C@@H](C(=C(C4=O)C(=O)N)O)N(C)C)O)O)O.OP(=O)(O)O.

UNSPSC 51284031 Doxycycline phosphate is a Commodity code capturing pharmaceutical products—specifically doxycycline formulations in tablet and capsule form—that state and local health departments and county health agencies procure for public health stock, emergency preparedness, and community health programs. State and local governments buy this antibiotic through piggyback cooperative purchasing vehicles and competitive bidding to support disease prevention, pandemic preparedness, and treatment availability at public health facilities. The Illinois Department of Public Health is a principal buyer under this code, using cooperative purchasing consortia such as MMCAP Infuse to aggregate volume and access pre-negotiated pricing from pharmaceutical wholesalers.

Recent procurement activity shows limited scope: the Illinois Department of Public Health awarded a piggyback contract to Chartwell Rx LLC on August 28, 2026 for doxycycline hyclate 100mg tablets and ciprofloxacin hydrochloride 500mg tablets under Bid Number 26-482DPH-PREPD-B-53392, a completed ITB with a total award of $2,999,999.11 over 12 months plus two one-year renewal options. The source contains one other recent opportunity (Seminole County, Florida, June 2026) but that solicitation targets naloxone and drug deactivation systems—products outside the doxycycline phosphate scope—suggesting minimal recent activity specifically under this Commodity code. Illinois represents the primary documented jurisdiction with recent doxycycline procurement activity.